As Dow Hits 14,000 IPOs Hit Stride Again
Week of October 1, 2007
BioHeart (BHRT) biotech for heart damage treatment: C, 6
China Digital TV (STV) digital television access systems in China: C+, 8
Constant Contact (CTCT) on-demand email marketing solutions: C, 6
MAP Pharma (MAPP) inhalable drugs for asthma: C, 6
Merrion Pharma (MERR) oral dosage forms of drugs: C, 6
IPOs that did very well in the IPO aftermarket the last half of the September 2007 quarter. VMware (VMW) B, 10. lululemon athletica (LULU) B-, 8. WuXi Pharma Tech (WX) B-, 9.
E-House (China) (EJ) B-, 9
Go to Mr. Gaskins Website for more details!
BioHeart (BHRT) biotech for heart damage treatment: C, 6
China Digital TV (STV) digital television access systems in China: C+, 8
Constant Contact (CTCT) on-demand email marketing solutions: C, 6
MAP Pharma (MAPP) inhalable drugs for asthma: C, 6
Merrion Pharma (MERR) oral dosage forms of drugs: C, 6
IPOs that did very well in the IPO aftermarket the last half of the September 2007 quarter. VMware (VMW) B, 10. lululemon athletica (LULU) B-, 8. WuXi Pharma Tech (WX) B-, 9.
E-House (China) (EJ) B-, 9
Go to Mr. Gaskins Website for more details!
Labels: analysis, china, gaskins, investing, IPO, marketing, Pharma, stock market, stock pick, streetiq, wall street
posted by streetiq at
9:08 AM
1 Comments
